Key facts
- This page summarizes Moncef Slaoui's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Option shall vest over 36 months, 1/3 of which will vest on June 17, 2027 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.